Literature DB >> 17584406

Microbial contamination of nebulizers in the home treatment of cystic fibrosis.

H Blau1, H Mussaffi, M Mei Zahav, D Prais, M Livne, B M Czitron, H A Cohen.   

Abstract

BACKGROUND: Home nebulizers are in widespread use in cystic fibrosis (CF) and other chronic pulmonary diseases. Bacterial contamination may be a source of respiratory tract colonization.
OBJECTIVES: To investigate microbial contamination of home nebulizers in CF patients, compare with sputum cultures and relate to cleaning practices.
METHODS: A total of 29 home nebulizers of CF patients were cultured. Families were interviewed regarding cleaning routines and patients had sputum cultures for bacteria and fungi.
RESULTS: In total, 19/29 (65%) nebulizers were contaminated: 18 reservoir cups, 14 mouthpieces and five filters. Pseudomonas spp. were isolated from 10 nebulizers (35%) and all 10 had Pseudomonas aeruginosa airway infection although without genetic typing we could not be sure this was the same bacteria as that from their nebulizer unit. An additional 7/29 had Pseudomonas aeruginosa airway infection without a contaminated nebulizer (P=0.001). No nebulizers were contaminated with Aspergillus. Only 4/19 contaminated nebulizers (22%) had been cleaned after every use, compared with seven of the 10 (70%) uncontaminated nebulizers (P=0.017). Only 7/19 patients with contaminated nebulizers (37%) and 5/10 with clean nebulizers (50%) recalled receiving cleaning instructions (not significant).
CONCLUSIONS: Home nebulizers are frequently contaminated, particularly when cleaning instructions are inadequate, and may be a source of airway infection or reinfection especially following contamination from a patient chronically colonized with P. aeruginosa. Simple oral and written cleaning instructions should be offered.

Entities:  

Mesh:

Year:  2007        PMID: 17584406     DOI: 10.1111/j.1365-2214.2006.00669.x

Source DB:  PubMed          Journal:  Child Care Health Dev        ISSN: 0305-1862            Impact factor:   2.508


  17 in total

1.  Preferences and Stated Adherence for Antibiotic Treatment of Cystic Fibrosis Pseudomonas Infections.

Authors:  Ateesha Farah Mohamed; F Reed Johnson; Maria-Magdalena Balp; Frederico Calado
Journal:  Patient       Date:  2016-02       Impact factor: 3.883

Review 2.  Devices for dry powder drug delivery to the lung.

Authors:  Kai Berkenfeld; Alf Lamprecht; Jason T McConville
Journal:  AAPS PharmSciTech       Date:  2015-05-12       Impact factor: 3.246

Review 3.  A Systematic Review on KAP of Nebulization Therapy at Home.

Authors:  Shalini Sivadasan; Akshaya Krishnan; Sathish Venkatasamy Dhayalan; Rajasekaran Aiyalu
Journal:  J Pharm Technol       Date:  2021-07-11

4.  First report of isolation and characterization of Aurantimonas altamirensis from clinical samples.

Authors:  Me-Linh Luong; Sadjia Békal; Donald C Vinh; Dominique Lauzon; Vicki Leung; Ghada N Al-Rawahi; Betty Ng; Tamara Burdz; Kathryn Bernard
Journal:  J Clin Microbiol       Date:  2008-05-21       Impact factor: 5.948

5.  Nebuliser cleaning and disinfection practice in the home among patients with cystic fibrosis.

Authors:  Mary MacFarlane; Lesley Carson; Amanda Crossan; Jane Bell; John E Moore; B Cherie Millar
Journal:  J Infect Prev       Date:  2019-06-21

6.  Patients' practices and experiences of using nebuliser therapy in the management of COPD at home.

Authors:  B Alhaddad; F J Smith; T Robertson; G Watman; K M G Taylor
Journal:  BMJ Open Respir Res       Date:  2015-02-24

7.  Microbial contamination of domiciliary nebulisers and clinical implications in chronic obstructive pulmonary disease.

Authors:  S Jarvis; P W Ind; C Thomas; S Goonesekera; R Haffenden; A Abdolrasouli; F Fiorentino; R J Shiner
Journal:  BMJ Open Respir Res       Date:  2014-02-27

8.  Persistent Pseudomonas aeruginosa infection associated with non-invasive ventilation in a child with spinal muscular atrophy type 1.

Authors:  Archana Chacko; Peter D Sly; Tim Kidd; Leanne Gauld
Journal:  J Clin Sleep Med       Date:  2021-03-01       Impact factor: 4.062

9.  Effect that an educational program for cystic fibrosis patients and caregivers has on the contamination of home nebulizers.

Authors:  Adriana Della Zuana; Doroti de Oliveira Garcia; Regina Célia Turola Passos Juliani; Luiz Vicente Ribeiro Ferreira da Silva Filho
Journal:  J Bras Pneumol       Date:  2014 Mar-Apr       Impact factor: 2.624

10.  Cleaning and infection control of airway clearance devices used by CF patients.

Authors:  Eynav Manor; Michal Gur; Yuval Geffen; Lea Bentur
Journal:  Chron Respir Dis       Date:  2017-05-17       Impact factor: 2.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.